April 17, 2016
Trellis presents "Antibodies Targeting LAG-3 , TIM-3, KIR Cloned from Healthy Human Donors” at AACR

September 22, 2014
Trellis Bioscience announces Michael Greenberg joining the company as VP of Business Development

July 11, 2014
Trellis Bioscience and ContraFect Announce Infectious Disease Antibody License

March 17, 2014
Trellis Bioscience and Amorphix to collaborate on anti-CD38 antibody treatment for cancer

March 17, 2014
Trellis Bioscience to present results from work using its B-cell epitope identification and CellSpot antibody discovery technologies in the area of anti-drug antibodies at the May 20, 2014 AAPS National Biotechnology Conference